Kinarus Therapeutics Holding AG
SIX:KNRS

Watchlist Manager
Kinarus Therapeutics Holding AG Logo
Kinarus Therapeutics Holding AG
SIX:KNRS
Watchlist
Price: 15 CHF 416 566.67%
Market Cap: 19.5B CHF

Intrinsic Value

KNRS doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of KNRS.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KNRS Intrinsic Value
Not Available
Base Case Scenario

Fundamental Analysis

Kinarus Therapeutics Holding AG
SIX:KNRS
CH
Airlines
Market Cap
19.5B CHF
IPO
Oct 18, 1999
CH
Airlines
Market Cap
19.5B CHF
IPO
Oct 18, 1999
Price
CHffalse
EPS
CHffalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Kinarus Therapeutics Holding AG
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Kinarus Therapeutics Holding AG

Balance Sheet Decomposition
Kinarus Therapeutics Holding AG

Current Assets 111k
Receivables 108k
Other Current Assets 3k
Efficiency

Free Cash Flow Analysis
Kinarus Therapeutics Holding AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Kinarus Therapeutics Holding AG

Revenue
0 CHF
Operating Expenses
-13.9m CHF
Operating Income
-13.9m CHF
Other Expenses
-6k CHF
Net Income
-13.9m CHF
Fundamental Scores

KNRS Profitability Score
Profitability Due Diligence

Kinarus Therapeutics Holding AG's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Negative Free Cash Flow
Negative Net Income
Negative Operating Income
36/100
Profitability
Score

Kinarus Therapeutics Holding AG's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

KNRS Solvency Score
Solvency Due Diligence

Kinarus Therapeutics Holding AG's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
57/100
Solvency
Score

Kinarus Therapeutics Holding AG's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KNRS Price Targets Summary
Kinarus Therapeutics Holding AG

There are no price targets for KNRS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Kinarus Therapeutics Holding AG
does not pay dividends
Shareholder Yield

Current shareholder yield for KNRS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

KNRS Insider Trading
Buy and sell transactions by insiders